Text or WhatsApp Richard at (808) 600-9260
Lion crestHealthcareInvestmentBanking.com

Healthcare Deal Calculators: Valuation, Proceeds, Rollover, Earnout, Debt Capacity and Raise Size

An owner needs six numbers before signing an LOI: value, cash at close, rolled equity, earnout, debt capacity and raise size. Each calculator below gives its formula in one line, its default inputs and its default result. One worked case then runs a single practice through all six, on one set of inputs.

Data as of November 20, 2026. Every worked example uses hypothetical inputs, and every derived figure is our arithmetic. Each benchmark names its source, population and date where it appears.

The 6 calculators at a glance

Calculator Question it answers Formula (one line) Default worked result
Practice Valuation What is the business worth? EV = adjusted EBITDA × multiple. Equity value = EV − net debt $1.2M × 4x to 7x = $4.8M to $8.4M EV
Deal Proceeds How much cash lands at close? Cash = headline EV − earnout − net debt ± working capital − costs − rollover % × guaranteed equity value − escrow % × guaranteed EV $52.8M headline leaves $28.76M at close, pre-tax (54.5%)
Rollover Equity What is the rolled stake worth at the second sale? Stake = (rollover ÷ entry equity) × (exit EBITDA × exit multiple − remaining debt) × (1 − pool %) $6M roll worth $15.7M at an 11x exit (2.62x)
Earnout Value What is the contingent pay worth today? PV = Σ (maximum × probability ÷ N) ÷ (1 + rate)^(year + delay) $3M maximum at 40% = $941,932 at close
Debt Capacity How much senior debt does cash flow support? Lower of [EBITDA × max leverage] and [(EBITDA − capex − cash taxes) ÷ min DSCR ÷ (rate + amortization)] $4.0M EBITDA supports $14.0M (leverage binds)
Capital Raise Sizing How much to raise, at what dilution? Gross raise = (burn × months + uses) × (1 + buffer) ÷ (1 − cost %). Dilution = raise ÷ (pre-money + raise) $4.625M raise, 27.82% dilution

Each calculator ships with its own default case. The proceeds default and the worked case below are the same $6.0 million EBITDA practice. The other defaults describe different hypothetical businesses.

One practice through all six calculators

The case (hypothetical): a multi-specialty physician group with $6.0 million of adjusted EBITDA receives a sponsor LOI at 8.8x. The $52.8 million headline includes a $5.0 million earnout, so the guaranteed price is $47.8 million, or 7.97x. Every result is our arithmetic.

Step Calculator and inputs Result
1. Value $6.0M × 8.8x (FOCUS 2026 dashboard, multi-specialty, $5M to $10M EBITDA) $52.8M headline EV
1a. Cross-check, wide Axia Growth middle half for closed healthcare sales at $5M to $10M EBITDA (n=14, as of Oct 28, 2026), 3.4x to 10.7x $20.4M to $64.2M
1b. Cross-check, high Sikich Q3 2026 indicative band for physician practices above $5M EBITDA, 11x to 13x $66.0M to $78.0M
2. Proceeds $4.0M net debt, $1.5M costs, 20% rollover on guaranteed equity value, 10% escrow on guaranteed EV $28.76M cash at close, pre-tax
3. Earnout $5.0M maximum, two annual tranches, 34.4% probability (assumed 80% chance of any payout × 43-cent SRS LMM median), 15% rate, 3-month delay $1.35M present value
4. Debt capacity (buyer's view) $6.0M EBITDA, 3.5x cap, $450K capex, $600K cash taxes, 9% interest, 5% amortization, 1.25x DSCR $21.0M, leverage binds. Coverage limit $28.29M. Coverage at capacity 1.68x
5. Rollover Entry EV $47.8M guaranteed, $21.0M new debt, entry equity $26.8M, $8.76M rolled (32.7%), 10% EBITDA growth for 5 years, 30% of debt repaid, 8% flat pool, exit at 7.97x $18.73M stake, 2.14x MOIC, 16.4% IRR
6. Raise (owners keep control instead) $0 burn, $4.0M for two de novo sites, 20% buffer, 4% costs, $48.8M pre-money ($52.8M less $4.0M net debt) $5.0M gross raise, 9.29% dilution

What the case shows.

1. Practice Valuation Calculator

Formula: EV = (reported EBITDA + owner-pay add-back ± rent adjustment) × multiple. Equity value = EV − net debt.

Default worked result: $1.2 million of adjusted EBITDA at 4x to 7x gives $4.8 million to $8.4 million of EV. The default multiple is FOCUS Investment Banking's 2026 band for small dermatology groups with $2 million to $15 million of revenue. Replace it with your own row below. Equity value comes before escrow, earnout, rollover, working capital, fees and taxes. It is not cash.

Estimate only. Educational, not investment advice.

Pick the multiple by specialty and size, then check it against a second dataset. Rows from different sources measure different populations, so they will not agree.

Specialty and size (population) Indicative EV/EBITDA Source and as-of date
Dermatology, solo, under $2M revenue 3x to 5x FOCUS, 2026 dermatology benchmarks
Dermatology, small group, $2M to $15M revenue 4x to 7x FOCUS, 2026
Dermatology, regional platform, $15M to $50M revenue 8x to 10x FOCUS, 2026
Dermatology, platform, $50M+ revenue or $10M+ EBITDA 12x to 15x FOCUS, 2026
Multi-specialty medical practice, $5M to $10M EBITDA 8.8x FOCUS, 2026 dashboard
All physician practices, under $1M / $1M to $3M / $3M to $5M / above $5M EBITDA 5x to 7x / 7x to 9x / 9x to 11x / 11x to 13x Sikich, Q3 2026
Dental, platform / add-on / practice 9x to 11x / 5x to 8x / 5x to 9x Sikich, Q3 2026
ASC, single-specialty / multispecialty / regional operator 5x to 8x / 6x to 10x / 11x to 17x Sikich, Q3 2026
Home health and hospice, small agencies Mid-single digits Sikich, Q3 2026
Urgent care, under $10M / $10M to $50M revenue 3x to 7x / 6x to 11x Sikich, Q3 2026
Closed healthcare small-business sales, $2M to $3M EBITDA (n=13) 5.1x median, 3.1x to 10.9x middle half Axia Growth, as of Oct 28, 2026
Closed healthcare small-business sales, $5M to $10M EBITDA (n=14) 8.8x median, 3.4x to 10.7x middle half Axia Growth, as of Oct 28, 2026
Closed healthcare small-business sales, $10M+ EBITDA (n=17) 12.9x median, 9.4x to 18.5x middle half Axia Growth, as of Oct 28, 2026
U.S. healthcare services control deals, all sizes 9.6x median (68 deals with positive EBITDA), 10.1x excluding distressed Buckhead FMV, Jan 2023 to Oct 2026

How to read it.

Owner pay decides most practice valuations. Worked example (hypothetical): two physician owners draw $1.4 million combined, and market replacement pay is $500,000 each. The add-back is $1.4 million − $1.0 million = $400,000. At 7x that adds $2.8 million of EV. It is also the first number a buyer's quality of earnings team tests. Profit distributions below the EBITDA line are not add-backs, because reported EBITDA already includes them.

2. Deal Proceeds Calculator

Formula: Cash at close = headline EV − earnout inside the headline − net debt ± working capital − transaction costs − (rollover % × guaranteed equity value) − (escrow % × guaranteed EV).

Default worked result: $28.76 million of a $52.8 million headline (54.5%) arrives at closing, pre-tax. That is 60.2% of the $47.8 million guaranteed price.

The base for every input. Contingent dollars are excluded from every percentage, so the seller never rolls or escrows money that may not be paid.

Input Default Base it applies to
Earnout inside the headline $5.0M Deducted in dollars. Set to $0 if the LOI pays it on top of the price
Net debt $4.0M Debt repaid from proceeds less cash the seller keeps, in dollars
Working capital adjustment $0 Delivered working capital minus the peg, in dollars
Transaction costs $1.5M (3.1% of guaranteed EV) Legal, accounting, advisory and your share of any RWI premium, gross dollars
Rollover 20% Guaranteed equity value = guaranteed EV − net debt
Escrow 10% Guaranteed EV = headline EV − earnout

Running total, default inputs (our arithmetic):

Line Calculation Amount Running total
Headline EV $6.0M × 8.8x $52.80M $52.80M
Earnout inside the headline Paid later or not at all −$5.00M $47.80M (guaranteed EV, 7.97x)
Net debt Repaid at close −$4.00M $43.80M (guaranteed equity value)
Working capital Set to zero to isolate other lines $0 $43.80M
Transaction costs Fixed dollars −$1.50M $42.30M
Rollover 20% × $43.80M −$8.76M $33.54M
Escrow 10% × $47.80M −$4.78M $28.76M cash at close

Check: $52.80M − $5.00M − $4.00M − $1.50M − $8.76M − $4.78M = $28.76M.

Expected cash after close (undiscounted, pre-tax, rollover excluded, escrow assumed released in full):

Earnout probability Cash at close + Escrow + Expected earnout Expected cash
50% $28.76M $4.78M $2.50M $36.04M
40% $28.76M $4.78M $2.00M $35.54M
34.4% (80% × 43-cent LMM median) $28.76M $4.78M $1.72M $35.26M

Escrow release is not certain. Indemnification claims and purchase price adjustments draw on it.

Estimate only. Educational, not investment advice.

Sensitivity: one input changed at a time from the $28.76M default (our arithmetic)

Change Calculation Cash at close Change
Earnout paid on top of $52.8M instead of inside it Guaranteed EV $52.8M, rollover $9.76M, escrow $5.28M $32.26M +$3.50M
Escrow at 2.8% (SRS median with RWI), premium excluded 2.8% × $47.8M = $1.34M $32.20M +$3.44M
Escrow at 11.1% (SRS median without RWI) 11.1% × $47.8M = $5.31M $28.23M −$0.53M
Escrow applied to headline EV instead 10% × $52.8M = $5.28M $28.26M −$0.50M
Transaction costs up $0.5M $2.0M costs $28.26M −$0.50M
Net debt up $1.0M Rollover falls $0.2M to $8.56M $27.96M −$0.80M
Rollover on headline equity value, earnout included 20% × $48.8M = $9.76M $27.76M −$1.00M
Working capital shortfall of $1.0M, rollover held constant $1.0M deduction $27.76M −$1.00M

Ask how the LOI defines each base. "20% rollover" on headline equity value instead of guaranteed equity value costs this seller $1.0 million of cash at close for dollars that may never be earned. Get the closing payment in dollars, not percentages.

Escrow benchmarks applied to the $47.8M guaranteed price. SRS Acquiom's 2026 Deal Terms for M&A Escrows covers 2025 deals across all industries, not practice sales alone.

Total escrow, % of transaction value (2025 deals) Rate Held back on $47.8M (our arithmetic)
With RWI, median 2.8% $1.34M
With RWI, average 5.1% $2.44M
Without RWI, median 11.1% $5.31M
Without RWI, average 14.7% $7.03M

The gap between the two medians is about $4.0 million paid at closing instead of at release.

From pre-tax to after-tax. The calculator stops at pre-tax. The illustration assumes a 28% combined rate on zero basis, all gain treated as capital gain. That is our assumption, chosen to size the swing, not a forecast.

Line What drives the tax Illustration (our arithmetic)
Cash at close Taxed in the year of sale $8.05M of tax, $20.71M after tax
Rollover Whether tax is deferred depends on how the roll is structured A roll that fails to defer adds $2.45M of tax at close on $8.76M of equity that pays no cash
Escrow and earnout Timing and character depend on the payment terms Do not assume capital gain at close

Deal form (asset or equity sale), state tax and your real basis all change the result. Rollover structure is often the largest tax swing in a practice sale, so settle it in the LOI.

3. Rollover Equity Calculator

Formula: Stake value = (rollover ÷ entry equity) × (exit EBITDA × exit multiple − remaining debt) × (1 − management pool %). Entry equity = entry EV − acquisition debt. MOIC = stake ÷ rollover. IRR = MOIC^(1 ÷ years) − 1.

Default inputs (hypothetical): a $30 million dental platform sale at 10x, so $3 million of EBITDA. Debt is 50% of EV, so entry equity is $15 million. $6 million rolled buys 40%. EBITDA grows 10% a year for five years, to $4.83 million. 30% of the $15 million debt is repaid, leaving $10.5 million. An 8% flat pool turns the seller's 40% into 36.8% of exit equity.

Default worked result (11x exit): exit EV of $53.1 million less $10.5 million of debt leaves $42.6 million of equity. 36.8% of that is $15.7 million, a 2.62x MOIC and a 21.2% IRR.

Estimate only. Educational, not investment advice.

Exit multiple Exit EV Exit equity Stake (36.8%) MOIC IRR
11x (default, one turn of expansion) $53.1M $42.6M $15.7M 2.62x 21.2%
10x (flat to entry) $48.3M $37.8M $13.9M 2.32x 18.3%
9x (one turn lower) $43.5M $33.0M $12.1M 2.02x 15.1%
8x (two turns lower) $38.7M $28.2M $10.4M 1.73x 11.5%

Integrated case, same formula (our arithmetic). In the $6.0 million practice, $8.76 million buys 32.7% of $26.8 million entry equity, or 30.1% after the pool. Exit EBITDA is $9.66 million and remaining debt $14.7 million.

Exit multiple Exit equity Stake MOIC IRR
8.8x (headline multiple, expansion) $70.33M $21.15M 2.41x 19.3%
7.97x (flat to guaranteed price) $62.28M $18.73M 2.14x 16.4%
6.97x (one turn lower) $52.62M $15.82M 1.81x 12.6%

Flat pool versus profits interest. Most pools are profits interests that share only in value above a threshold set at grant. In the dental default, an 8% pool with a $15 million threshold takes $2.21 million at the 11x exit, or 5.19% of exit equity. That lifts the stake to $16.2 million (2.70x). Enter the effective share, not the headline pool percentage.

Count multiple expansion as upside only. Two datasets, different populations:

Dataset (population) 2023 2024 2025 2026 to date
PitchBook median healthcare M&A EV/EBITDA, reported by Sikich (all healthcare M&A) n/a 14.5x 13x 11.6x (through Q3)
Buckhead FMV median EV/EBITDA (U.S. healthcare services control deals) 11.4x 9.7x 6.5x 9.1x (through October)

Buckhead's yearly cells split 68 EBITDA-positive deals across four years, so year-to-year moves are weak evidence. Buckhead attributes the 2025 dip to a smaller, more mid-market mix rather than a broad repricing. Neither series shows multiples rising.

The tables assume rollover is common equity bought at the sponsor's price. An accruing sponsor preferred cuts weak-case value sharply. In the rollover page's weak-exit hypothetical, an 8% non-participating preferred cuts a $6 million roll from $6.55 million to $3.16 million.

4. Earnout Value Calculator

Formula: PV = Σ over years 1 to N of (maximum × probability ÷ N) ÷ (1 + discount rate)^(year + payment delay).

Probability carries the risk the target is missed. The discount rate carries time value and buyer credit, since an earnout is usually an unsecured claim behind senior lenders. Putting achievement risk in both double-counts it.

Default worked result: $3 million maximum, two annual periods, 40% probability, 15% rate, three-month delay. Expected payout is $1.2 million, or $600,000 per tranche. Tranche 1 at 1.25 years is worth $503,824. Tranche 2 at 2.25 years is worth $438,108. Total $941,932, or 31.4% of face.

Estimate only. Educational, not investment advice.

Build the probability in two parts: chance of any payout × share of the maximum paid when it pays. SRS Acquiom's 2026 M&A Earnout and Milestone Trends reports only the second part, because its medians exclude earnouts that paid nothing.

Probability build Chance of any payout (assumed) Cents paid when it pays Enter
SRS lower middle-market median (all industries) 80% 43 34.4%
Calculator default 80% 50 40%
SRS median, upfront above $50M 80% 67 53.6%

The 40% default is seller-favorable for a lower middle-market deal. Run 34.4% beside it.

Structure and rate sensitivity ($3M maximum, 3-month delay, our arithmetic):

Structure Probability Rate Present value
Equal annual tranches 60% 15% $1,412,899
Equal annual tranches (default) 40% 15% $941,932
Equal annual tranches 34.4% 15% $810,062
Equal annual tranches 40% 10% $1,016,808
Equal annual tranches 40% 20% $875,824
Back-loaded 30/70 40% 15% $915,646
Two-year cumulative cliff, paid at 2.25 years 40% 15% $876,216
Two-year cumulative cliff, paid at 2.25 years 30% 15% $657,162

For back-loaded, cliff or milestone schedules, run each tranche separately and add them. If the deal only works at the lowest rate, the earnout carries too much of the price.

5. Debt Capacity Calculator

Formula: Capacity = lower of [EBITDA × max leverage] and [(EBITDA − maintenance capex − cash taxes) ÷ min DSCR ÷ (interest rate + amortization rate)].

Default worked result: $4.0 million of EBITDA supports $14.0 million of senior debt, and leverage binds.

Line Calculation Result
Leverage limit $4.0M × 3.5x $14.0M
Cash flow available for debt service $4.0M − $0.3M capex − $0.4M taxes $3.3M
Coverage limit $3.3M ÷ 1.25 ÷ (9% + 5%) $18.86M
Debt capacity Lower of the two $14.0M
Annual debt service $14.0M × 14% $1.96M
Coverage at capacity $3.3M ÷ $1.96M 1.68x

Estimate only. Educational, not investment advice.

What the model leaves out. One fixed rate and level amortization at closing. No floating-rate resets, upfront fees, cash sweeps or covenants beyond leverage and DSCR. For a multi-tranche stack, enter balance-weighted blended rates and include any seller note, because it draws on the same cash flow.

Fixed charge coverage. Some lenders test fixed charge coverage instead of DSCR, adding rent back above the line and counting it as a fixed charge below. That only applies when EBITDA is measured after rent. If your EBITDA is already stated before rent, rent is already in the numerator, so add it only to the denominator. On the after-rent basis, $1.0 million of rent moves coverage from 1.68x to 1.45x: ($3.3M + $1.0M) ÷ ($1.96M + $1.0M).

Which test binds shifts as the cap rises. Sikich's Q3 2026 update, citing PitchBook, puts 2025 entry leverage for PE-backed healthcare services buyouts at 5.2x EBITDA. At 5.2x the default business shows a $20.8 million leverage limit, so the $18.86 million coverage limit binds. Smaller practice acquisitions often finance through the SBA 7(a) loan program. For a level-payment loan, set amortization so rate plus amortization equals the year-one payment ÷ principal.

Borrow below capacity. At 3.0x the default business borrows $12.0 million, debt service drops to $1.68 million and coverage rises to 1.96x. With that balance fixed, EBITDA can fall 14.3% (to $3.43 million) before a 3.5x covenant trips. That is the room to lose a payer contract without a breach.

6. Capital Raise Sizing Calculator

Formula: Gross raise = (monthly burn × runway months + uses of funds) × (1 + buffer %) ÷ (1 − transaction cost %). Dilution = gross raise ÷ (pre-money + gross raise).

Default worked result: $150,000 × 18 months = $2.7 million. Plus $1.0 million of uses = $3.7 million. A 20% buffer gives $4.44 million. ÷ 0.96 for 4% costs = $4.625 million gross, of which $185,000 is costs. At $12 million pre-money, dilution is 27.82%.

Estimate only. Educational, not investment advice.

Scenario Gross raise Pre-money Dilution
Default, 18 months $4.625M $12.0M 27.82%
Same need, higher pre-money $4.625M $16.0M 22.42%
24 months of runway $5.75M $12.0M 32.39%

Six extra months of runway cost 4.57 points of ownership. A milestone that lifts pre-money by $4 million saves 5.40 points. Pre-money is equity value, so subtract net debt and debt-like items from EV first. Headline dilution excludes option pools carved from the pre-money, converting notes or SAFEs and liquidation preferences. Each raises effective dilution. The 4% cost default is our modeling assumption. Replace it with your engagement letter figures.

Market inputs that move every output

Input Benchmark Source, population and date Feeds
Size band 5x to 7x EBITDA below $1M, 11x to 13x above $5M Sikich, physician practices, Q3 2026 Valuation, proceeds, rollover
Escrow 2.8% median with RWI, 11.1% without SRS Acquiom, 2025 deals, all industries Proceeds
Earnout realization 43 cents (LMM) and 67 cents (upfront above $50M) per dollar, among earnouts that paid SRS Acquiom 2026 earnout study Earnout, proceeds
Entry leverage 5.2x EBITDA PitchBook via Sikich, PE-backed healthcare services buyouts, 2025 Debt capacity, rollover

Who is buying. PESP's 2025 review, drawing on PitchBook and LevinPro HC, tracked 1,029 PE-backed healthcare deals in 2025, of which 664 (64.5%, our arithmetic) were add-ons. PESP says its count is likely an underestimate. In outpatient care, PESP data reported by Becker's ASC Review counts 148 deals, 119 of them add-ons (80.4%). Dermatology led with 24, eye care had 22 and oncology 9. Most practice sellers are pricing an add-on, so run the lower half of each band. Bain & Company estimates global provider and related services PE deal value rose 57% to $62 billion in 2025, on actuals through November 30, 2025, annualized.

Hospital deals sit in a different size class. Kaufman Hall's Q3 2026 report (October 13, 2026) counted 16 hospital and health system deals in the quarter, with average seller revenue near $586 million. Those deals carry regulatory timelines a single practice sale usually does not.

Inputs to pull from your records before running the calculators

Every default on this page is a starting assumption. The results become useful only once each one is replaced with a figure from your own books or your LOI. Gather these before the first run, so a buyer's numbers and yours start from the same base.

Input Where to find it Calculators it feeds Default in the worked case
Adjusted EBITDA, trailing twelve months Monthly financials, owner pay add-back worksheet, quality of earnings report if one exists Valuation, debt capacity, rollover $6.0M
Specialty and size row Multiples table in section 1 Valuation 8.8x
Earnout amount, and whether it sits inside the headline LOI Proceeds, earnout $5.0M inside the headline
Earnout tranches and payment delay LOI or first draft of the purchase agreement Earnout Two annual tranches, 3-month delay
Net debt Loan and equipment lease statements, projected cash at close Proceeds, raise sizing $4.0M
Working capital peg LOI or buyer proposal, against your trailing twelve-month average Proceeds $0
Transaction costs Engagement letters for legal, accounting and advisory, plus any RWI quote Proceeds $1.5M
Rollover percentage and its base LOI Proceeds, rollover 20% of guaranteed equity value
Escrow percentage and its base, with or without RWI LOI Proceeds 10% of guaranteed EV
Maintenance capex and cash taxes Fixed asset ledger, prior tax returns Debt capacity $450K and $600K
Lender terms Debt term sheet: leverage cap, DSCR, rate, amortization Debt capacity 3.5x, 1.25x, 9%, 5%
Exit assumptions Sponsor's model and your growth plan Rollover 10% growth, 7.97x exit, 8% pool
Tax basis Prior returns, your accountant After-tax lines Zero

Model the closing date as well as the price. Cash at close arrives only when the deal closes. In the worked case, a six-month slip on the $28.76 million closing payment, at an assumed 8% cost of money, reduces its present value by about $1.09 million (our arithmetic), and it also pushes back the escrow release and the earnout clock. Run the proceeds calculator against the latest close date you think is realistic, not the earliest.

Reviews of physician referral relationships, ownership structure and the transaction itself can move that date and shape how earnouts and physician pay are built. See healthcare compliance due diligence guide and healthcare M&A process guide. For a capital raise, see Capital Raising for Healthcare Companies, and take the questions those pages raise to your own attorney.

Where to start by situation

Situation Run in this order Read next
Selling Valuation → proceeds → after-tax lines → earnout if any price is contingent Selling a Physician Practice, LOI red flags checklist
Recapitalizing Valuation → rollover → debt capacity Healthcare Recapitalization
Raising Raise sizing → debt capacity, to see how much debt can fund without dilution Capital Raising for Healthcare Companies
Investing Debt capacity to frame the equity check → earnout and rollover to price seller alignment How Family Offices Invest in Healthcare

Sector multiples in more detail: Healthcare Valuation Multiples by Sector and Specialty.

Questions owners ask

Which calculator should I run first if I am thinking about selling?

Start with practice valuation to set an enterprise value range. Then run deal proceeds to turn that range into cash at close. If any part of the price is contingent, add the earnout calculator. The worked case above runs one $6.0 million EBITDA practice through all six calculators.

Why does the valuation default use 4x to 7x when the size table shows 7x to 9x for $1M to $3M of EBITDA?

The ranges come from different datasets. The 4x to 7x default is FOCUS Investment Banking's 2026 band for small dermatology groups with $2 million to $15 million of revenue. The 7x to 9x band is Sikich's Q3 2026 range for all physician practices with $1 million to $3 million of EBITDA. If you are not in dermatology, replace the default with the row for your specialty and size.

Why does the proceeds calculator ask whether the deal has RWI?

RWI changes how much of the price is held back. SRS Acquiom's 2026 escrow report, covering 2025 deals across all industries, puts median total escrow at 2.8% with RWI and 11.1% without. On a $20 million sale that is $560,000 against $2.22 million (our arithmetic). Enter your share of the RWI premium as a transaction cost so the cases compare like for like.

Is the rolled equity taxed at closing?

Many sponsor deals are structured so the rolled portion defers tax and the cash portion is taxed at closing. Whether a specific roll defers tax depends on how it is structured, so tax counsel has to confirm the structure before you sign the LOI. In this page's example, at an assumed 28% rate on zero basis, a roll that fails to defer costs about $2.45 million at closing on $8.76 million of equity that pays no cash.

Are these calculators useful for investors as well as owners?

Yes. Family offices and PE sponsors run the same math from the other side. Debt capacity sets the equity check. Rollover shows what management's retained stake is worth at exit. Earnout prices the contingent consideration the buyer is promising.

Sources